Back to CVE records
Medium 6.4Published Jul 14, 2026

CVE-2026-4018TOCTOU race condition in the QNX Neutrino kernel impacts versions of the QNX Software Development Platform and QNX OS for Safety

Updated under an hour ago ()

Does this affect you?

It affects BlackBerry Ltd QNX Software Development Platform and 2 other products. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

TOCTOU Race Condition in specific trace commands of the TraceEvent() system call could allow an attacker with local access and with the PROCMGR_AID_TRACE ability, to cause information disclosure, data tampering or a crash of the QNX Neutrino kernel.

CVSS
6.4 MEDIUM (v3.1, CNA)CVSS:3.1/AV:L/AC:H/PR:H/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-367
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
blackberry
NVD analysis
Deferred
Record last updated
Jul 15, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
BlackBerry Ltd QNX Software Development Platform
blackberry:qnx_software_development_platform (from the name)
7.1; cpe:2.3:a:blackberry:qnx_software_development_platform:7.1:*:*:*:*:*:*:*; 7.0; cpe:2.3:a:blackberry:qnx_software_development_platform:7.0:*:*:*:*:*:*:*
CNA record
BlackBerry Ltd QNX OS for Safety
blackberry:qnx_os_for_safety (from the name)
2.2.8 and earlier; cpe:2.3:o:blackberry:qnx_os_for_safety:2.2:8:*:*:*:*:*:*; 2.1.5 and earlier; cpe:2.3:o:blackberry:qnx_os_for_safety:2.1:5:*:*:*:*:*:*; 2.0.3 and earlier; cpe:2.3:o:blackberry:qnx_os_for_safety:2.0:3:*:*:*:*:*:*
CNA record
BlackBerry Ltd. QNX OS for Medical
blackberry:qnx_os_for_medical (from the name)
2.0.2 and earlier; cpe:2.3:o:blackberry:qnx_os_for_medical:2.0:2:*:*:*:*:*:*
CNA record

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.